Topics
March 2014 | Business Of Retina
The Use of Modifier Code -25 for Medicare and Medicaid Billing
Trexler M. Topping, MD
August 4, 2026
University of Iowa Research Underpins First-in-Human UK Study of Gene Therapy Targeting Rare IRD
Swedish Study Finds Small Absolute Risk of NAION Among GLP-1 Receptor Agonist Users
Opus Genetics Completes Enrollment in Phase 3 Trial of Gene Therapy for Inherited Retinal Disease
August 3, 2026
Biocon Launches Aflibercept Biosimilar Yesafili in the US
July/August 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
July/August 2026 Supplement
Editorially Independent Content, Supported With Advertising From Astellas and ZEISS
July 2026 Supplement
Free Print Subscription
Email Newsletter
Conference Calendar
_1784132761.jpg?auto=compress,format&w=70)
